Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase

Oncogene

Volumn 23, Issue 44, 2004, Pages 7330-7344

  Nakshatri, Harikrishna ^a,b,c   Rice, Susan E ^a   Bhat Nakshatri, Poornima ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTHER CANCER INSTITUTE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Breast cancer; JNK; NF B; Parthenolide; TRAIL

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CASPASE 8; CYTOCHROME C; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PARTHENOLIDE; PROTEIN BID; REACTIVE OXYGEN METABOLITE; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SESQUITERPENE LACTONE; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; FIBROBLASTS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OXIDATIVE STRESS; SESQUITERPENES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 6044240634     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207995     Document Type: Article

References (65)

1. Baldwin AS. (2001). J. Clin. Invest., 107, 241-246.
2. Beg AA and Baltimore D. (1996). Science, 274, 782-784.
3. Berman PA and Adams PA. (1997). Free Radic. Biol. Med., 22, 1283-1288.
4. Bernard D, Quatannens B, Vandenbunder B and Abbadie C. (2001). J. Biol. Chem., 276, 27322-27328.
5. Berns EM, Foekens JA, Vossen R, Look MP, Devilee P, Henzen-Logmans SC, van Staveren IL, van Putten WL, Inganas M, Meijer-van Gelder ME, Cornelisse C, Claassen CJ, Portengen H, Bakker B and Klijn JG. (2000). Cancer Res., 60, 2155-2162.
6. Bhat-Nakshatri P, Newton TR, Goulet Jr R and Nakshatri H. (1998). Proc. Natl. Acad Sci. USA, 95, 6971-6976.
7. Biswas DK, Cruz AP, Gansberger E and Pardee AB. (2000). Proc. Natl. Acad. Sci. USA, 97, 8542-8547.
8. Bratton SB and Cohen GM. (2003). Cell Death Differ., 10, 4-6.
9. Bykov VJ, Issaeva N, Shilov A, Hultcrantz M, Pugacheva E, Chumakov P, Bergman J, Wiman KG and Selivanova G. (2002). Nat. Med., 8, 282-288.
10. Chauhan D, Li G, Hideshima T, Podar K, Mitsiades C, Mitsiades N, Munshi N, Kharbanda S and Anderson KC. (2003). J. Biol. Chem., 278, 17593-17596.
11. Chinnaiyan AM, Prasad U, Shankar S, Hamstra DA, Shanaiah M, Chenevert TL, Ross BD and Rehemtulla A. (2000). Proc. Natl. Acad. Sci. USA, 97, 1754-1759.
12. Daniel PT, Wieder T, Sturm I and Schulze-Osthoff K. (2001). Leukemia, 15, 1022-1032.
13. Davis RJ. (2000). Cell, 103, 239-252.
14. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, Cong R and Franzoso G. (2001). Nature, 414, 308-313.
15. Deng Y, Ren X, Yang L, Lin Y and Wu X. (2003). Cell, 115, 61-70.
16. Desagher S, Osen-Sand A, Montessuit S, Magnenat E, Vilbois F, Hochmann A, Journot L, Antonsson B and Martinou JC. (2001). Mol. Cell, 8, 601-611.
17. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS and Reed JC. (1999). EMBO J., 18, 5242-5251.
18. Eid MA, Lewis RW, Abdel-Mageed AB and Kumar MV. (2002). Int. J. Oncol., 21, 111-117.
19. Hehner SP, Heinrich M, Bork PM, Vogt M, Ratter F, Lehmann V, Schulze-Osthoff K, Dröge W and Schmitz ML. (1998). J. Biol. Chem., 273, 1288-1297.
20. Hehner SP, Hofmann TG, Droge W and Schmitz ML. (1999). J. Immunol., 163, 5617-5623.
21. Hell K, Saleh M, Crescenzo GD, O'Connor-McCourt MD and Nicholson DW. (2003). Cell Death Differ., 10, 1234-1239.
22. Herr I, Wilhelm D, Meyer E, Jeremias I, Angel P and Debatin KM. (1999). Cell Death Differ., 6, 130-135.
23. Javelaud D and Besancon F. (2001). Oncogene, 20, 4365-4372.
24. Johnstone RW, Ruefli AA and Lowe SW. (2002). Cell, 108, 153-164.
25. Karin M, Cao Y, Greten FR and Li ZW. (2002). Nat. Rev. Cancer, 2, 301-310.
26. Kennedy NJ and Davis RJ. (2003). Cell Cycle, 2, 199-201.
27. Kim EH, Kim SU, Shin DY and Choi KS. (2004). Oncogene, 23, 446-456.
28. Lamb JA, Ventura JJ, Hess P, Flavell RA and Davis RJ. (2003). Mol. Cell, 11, 1479-1489.
29. Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D, Mounho B, Hillan K, Totpal K, DeForge L, Schow P, Hooley J, Sherwood S, Pai R, Leung S, Khan L, Gliniak B, Bussiere J, Smith CA, Strom SS, Kelley S, Fox JA, Thomas D and Ashkenazi A. (2001). Nat. Med., 7, 383-385.
30. LeBlanc HN and Ashkenazi A. (2003). Cell. Death Differ., 10, 66-75.
31. Lei K and Davis RJ. (2003). Proc. Natl. Acad. Sci. USA, 100, 2432-2437.
32. Lin A. (2003). Bioessays, 25, 17-24.
33. Luo X, Budihardjo I, Zou H, Slaughter C and Wang X. (1998). Cell, 94, 481-190.
34. Martins LM, Turk BE, Cowling V, Borg A, Jarrell ET, Cantley LC and Downward J. (2003). J. Biol. Chem., 278, 49417-49427.
35. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet Jr RJ and Sledge Jr GW. (1997). Mol. Cell Biol, 17, 3629-3639.
36. Nakshatri H and Goulet Jr RJ. (2002). Curr. Probl. Cancer, 26, 282-309.
37. Newton TR, Patel NM, Bhat-Nakshatri P, Stauss CR, Goulet Jr RJ and Nakshatri H. (1999). J. Biol. Chem., 274, 18827-18835.
38. Ng CP, Zisman A and Bonavida B. (2002). Prostate, 53, 286-299.
39. Nicholson RI, Hutcheson IR, Harper ME, Knowlden JM, Barrow D, McClelland RA, Jones HE, Wakeling AE and Gee JM. (2001). Endocr. Relat. Cancer, 8, 175-182.
40. Nozaki S, Sledge Jr GW and Nakshatri H. (2000). Biochem. Biophys. Res. Commun., 275, 60-62.
41. Ozoren N and El-Deiry WS. (2003). Semin. Cancer Biol., 13, 135-147.
42. Patel NM, Nozaki S, Shortle NH, Bhat-Nakshatri P, Newton TR, Rice S, Gelfanov V, Boswell SH, Goulet Jr RJ, Sledge Jr GW and Nakshatri H. (2000). Oncogene, 19, 4159-4169.
43. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K and Cobb MH. (2001). Endocr. Rev., 22, 153-183.
44. Pozarowski P, Halicka DH and Darzynkiewicz Z. (2003a). Cell Cycle, 2, 377-383.
45. Pozarowski P, Halicka DH and Darzynkiewicz Z. (2003b). Cytometry., 54A, 118-124.
46. Reuther-Madrid JY, Kashatus D, Chen S, Li X, Westwick J, Davis RJ, Earp HS, Wang Jr CY and Baldwin Jr AS. (2002). Mol. Cell Biol., 22, 8175-8183.
47. Ritter CA and Arteaga CL. (2003). Semin. Oncol., 30, 3-11.
48. Sah NK, Munshi A, Kurland JF, McDonnell TJ, Su B and Meyn RE. (2003). J. Biol. Chem., 278, 20593-20602.
49. Shaulian E and Karin M. (2002). Nat. Cell. Biol., 4, E131-E136.
50. Singh TR, Shankar S, Chen X, Asim M and Srivastava RK. (2003). Cancer Res., 63, 5390-5400.
51. Sobota R, Szwed M, Kasza A, Bugno M and Kordula T. (2000). Biochem. Biophys. Res. Commun., 267, 329-333.
52. Sontag E, Sontag JM and Garcia A. (1997). EMBO J., 16, 5662-5671.
53. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K and Takahashi R. (2001). Mol. Cell, 8, 613-621.
54. Suzuki Y, Takahashi-Niki K, Akagi T, Hashikawa T and Takahashi R. (2004). Cell Death Differ., 11, 208-216.
55. Swantek JL, Cobb MH and Geppert TD. (1997). Mol. Cell. Biol., 17, 6274-6282.
56. Tang F, Tang G, Xiang J, Dai Q, Rosner MR and Lin A. (2002). Mol. Cell. Biol., 22, 8571-8579.
57. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M and Lin A. (2001). Nature, 414, 313-317.
58. Vanhamme L and Szpirer C. (1988). Carcinogenesis, 9, 653-655.
59. Vivo C, Liu W and Broaddus VC. (2003). J. Biol. Chem., 278, 25461-25467.
60. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH. (1999). Nat. Med., 5, 157-163.
61. Wang CY, Cusack Jr JC, Liu R and Baldwin Jr AS. (1999). Nat. Med., 5, 412-417.
62. Wen J, You KR, Lee SY, Song CH and Kim DG. (2002). J. Biol. Chem., 277, 38954-38964.
63. Zhang XD, Nguyen T, Thomas WD, Sanders JE and Hersey P. (2000). FEBS Lett., 482, 193-199.
64. Zhang XD, Zhang XY, Gray CP, Nguyen T and Hersey P. (2001). Cancer Res., 61, 7339-7348.
65. Zhou Q, Fukushima P, DeGraff W, Mitchell JB, Stetler Stevenson M, Ashkenazi A and Steeg PS. (2000). Cancer Res., 60, 2611-2615.